Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men

Circulation

Volumn 107, Issue 9, 2003, Pages 1297-1302

  Björklund, Kristina ^a   Lind, Lars ^a   Zethelius, Björn ^a   Andrén, Bertil ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Blood pressure; Hypertension; Morbidity; Population

Indexed keywords

AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; THICKNESS;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 0037432311     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000054622.45012.12     Document Type: Article

References (31)

1. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792-2788.
2. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
3. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15:357-364.
4. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539-546.
5. Pickering TG, Coats A, Mallion JM, et al. Blood Pressure Monitoring: task force V. White-coat hypertension. Blood Press Monit. 1999;4:333-341.
6. Verdecchia P, Schillaci G, Borgioni C, et al. White-coat hypertension. Lancet. 1996;348:1444-1445.
7. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000;36:894-900.
8. Verdecchia P, Schillaci G, Boldrini F, et al. Variability between current definitions of "normal" ambulatory blood pressure: implications in the assessment of white coat hypertension. Hypertension. 1992;20:555-562.
9. Mancia G, Zanchetti A. White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens. 1996;14:1049-1052.
10. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564-572.
11. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-1392.
12. Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl. 1975;19:1-61.
13. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
14. Bjorklund K, Lind L, Lithell H. Twenty-four hour ambulatory blood pressure in a population of elderly men. J Intern Med. 2000;248:501-510.
15. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring: American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9:1-11.
16. Sobey WJ, Beer SF, Carrington CA, et al. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J. 1989;260:535-541.
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237: E214-E223.
18. World Health Organization. Diabetes mellitus: report of a WHO study group. Geneva: WHO; 1985. Technical Report Series 727.
19. Andren B, Lind L, Hedenstierna G, et al. Left ventricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J. 1996;17:1800-1807.
20. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
21. Mancia G. Reversed white-coat hypertension: definition, mechanisms and prognostic implications. J Hypertens. 2002;20:579-581.
22. Mann SJ, James GD, Wang RS, et al. Elevation of ambulatory systolic blood pressure in hypertensive smokers: a case-control study. JAMA. 1991;265:2226-2228.
23. Wing LM, Brown MA, Beilin LJ, et al. "Reverse white-coat hypertension" in older hypertensives. J Hypertens. 2002;20:639-644.
24. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25:871-878.
25. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
26. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
27. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264.
28. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-764.
29. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
30. Mancia G, Bombelli M, Lanzarotti A, et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population: Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med. 2002;162:582-586.
31. O'Brien E, Staessen J. Normotension and hypertension defined by 24-hour ambulatory blood pressure monitoring. Blood Press. 1995;4:266-282.